27
Participants
Start Date
May 31, 2015
Primary Completion Date
October 31, 2019
Study Completion Date
October 31, 2019
bendamustine plus rituximab
Bendamustine 90mg/m2 IV on days 1-2 up to 6th cycle Rituximab 375mg/m2 IV on day 1 at 1st cycle Rituximab 1400mg SC on day 1 from 2nd cycle every 4 weeks up to 8th cycle
Chonbuk National University Hospital, Jeonju
Hallym University Medical Center, Anyang-si
Chungnam National University, Daejeon
Gachon University Gil Medical Center, Incheon
Gyeongsang National University Hospital, Jinju
Seoul National University Bundang Hospital, Seongnam
Inje Universit, Seoul
Korea Cancer Center Hospital, Seoul
Seoul National University Boramae Hospital, Seoul
Seoul National University Hospital, Seoul
The Catholic University of Korea, Seoul
Gyeongsang National University Hospital
OTHER
Korea Cancer Center Hospital
OTHER
Seoul National University Boramae Hospital
OTHER
Hallym University Medical Center
OTHER
Inje University
OTHER
Gangnam Severance Hospital
OTHER
Chonbuk National University Hospital
OTHER
Chungnam National University
OTHER
The Catholic University of Korea
OTHER
Wonju Severance Christian Hospital
OTHER
Gachon University Gil Medical Center
OTHER
Seoul National University Bundang Hospital
OTHER
Seoul National University Hospital
OTHER